Filtros : "Indexado na Base de dados Index Medicus" "PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES" Removidos: "Antoniali, Cristina" "FORTES, ZULEICA BRUNO" "np" Limpar

Filtros



Refine with date range


  • Source: Journal of Sexual Medicine. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARNEIRO, Fernando Silva et al. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine, v. 6, n. 1, p. 115-125, 2009Tradução . . Acesso em: 05 nov. 2024.
    • APA

      Carneiro, F. S., Sturgis, L. C., Giachini, F. R. C., Carneiro, Z. N., Lima, V. V., Wynne, B. M., et al. (2009). TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine, 6( 1), 115-125.
    • NLM

      Carneiro FS, Sturgis LC, Giachini FRC, Carneiro ZN, Lima VV, Wynne BM, Martin SS, Brands MW, Passaglia R de CAT, Webb RC. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine. 2009 ; 6( 1): 115-125.[citado 2024 nov. 05 ]
    • Vancouver

      Carneiro FS, Sturgis LC, Giachini FRC, Carneiro ZN, Lima VV, Wynne BM, Martin SS, Brands MW, Passaglia R de CAT, Webb RC. TNF-'alfa' knockout mice have increased corpora cavernosa relaxation. Journal of Sexual Medicine. 2009 ; 6( 1): 115-125.[citado 2024 nov. 05 ]
  • Source: Expert Opinion on Therapeutic Targets. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIACHINI, Fernanda Regina Casagrande et al. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?. Expert Opinion on Therapeutic Targets, v. 12, n. 3, p. 327-339, 2008Tradução . . Disponível em: https://doi.org/10.1517/14728222.12.3.327. Acesso em: 05 nov. 2024.
    • APA

      Giachini, F. R. C., Callera, G. E., Carneiro, F. S., Passaglia, R. de C. A. T., & Webb, R. C. (2008). Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? Expert Opinion on Therapeutic Targets, 12( 3), 327-339. doi:10.1517/14728222.12.3.327
    • NLM

      Giachini FRC, Callera GE, Carneiro FS, Passaglia R de CAT, Webb RC. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? [Internet]. Expert Opinion on Therapeutic Targets. 2008 ; 12( 3): 327-339.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1517/14728222.12.3.327
    • Vancouver

      Giachini FRC, Callera GE, Carneiro FS, Passaglia R de CAT, Webb RC. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? [Internet]. Expert Opinion on Therapeutic Targets. 2008 ; 12( 3): 327-339.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1517/14728222.12.3.327
  • Source: Arteriosclerosis, Thrombosis Vascular Biology. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOGI, Alvaro et al. Endothelin-1, but not Ang II, activates MAP kinases through c-Src-independent Ras-Raf-dependent pathways in vascular smooth muscle cells. Arteriosclerosis, Thrombosis Vascular Biology, v. 27, n. 9, p. 1960-1967, 2007Tradução . . Acesso em: 05 nov. 2024.
    • APA

      Yogi, A., Callera, G. E., Montezano, A. C. I., Aranha, A. B., Passaglia, R. de C. A. T., Schiffrin, E. L., & Touyz, R. M. (2007). Endothelin-1, but not Ang II, activates MAP kinases through c-Src-independent Ras-Raf-dependent pathways in vascular smooth muscle cells. Arteriosclerosis, Thrombosis Vascular Biology, 27( 9), 1960-1967.
    • NLM

      Yogi A, Callera GE, Montezano ACI, Aranha AB, Passaglia R de CAT, Schiffrin EL, Touyz RM. Endothelin-1, but not Ang II, activates MAP kinases through c-Src-independent Ras-Raf-dependent pathways in vascular smooth muscle cells. Arteriosclerosis, Thrombosis Vascular Biology. 2007 ; 27( 9): 1960-1967.[citado 2024 nov. 05 ]
    • Vancouver

      Yogi A, Callera GE, Montezano ACI, Aranha AB, Passaglia R de CAT, Schiffrin EL, Touyz RM. Endothelin-1, but not Ang II, activates MAP kinases through c-Src-independent Ras-Raf-dependent pathways in vascular smooth muscle cells. Arteriosclerosis, Thrombosis Vascular Biology. 2007 ; 27( 9): 1960-1967.[citado 2024 nov. 05 ]
  • Source: The Journal of Pharmacology and Experimental Therapeutics. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PASSAGLIA, Rita de Cássia Aleixo Tostes et al. Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. The Journal of Pharmacology and Experimental Therapeutics, v. 322, n. 2, p. 678-685, 2007Tradução . . Acesso em: 05 nov. 2024.
    • APA

      Passaglia, R. de C. A. T., Giachini, F. R. C., Carneiro, F. S., Leite, R., Inscho, E. W., & Clinton Webb, R. (2007). Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. The Journal of Pharmacology and Experimental Therapeutics, 322( 2), 678-685.
    • NLM

      Passaglia R de CAT, Giachini FRC, Carneiro FS, Leite R, Inscho EW, Clinton Webb R. Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. The Journal of Pharmacology and Experimental Therapeutics. 2007 ; 322( 2): 678-685.[citado 2024 nov. 05 ]
    • Vancouver

      Passaglia R de CAT, Giachini FRC, Carneiro FS, Leite R, Inscho EW, Clinton Webb R. Determination of adenosine effects and adenosine receptors in murine corpus cavernosum. The Journal of Pharmacology and Experimental Therapeutics. 2007 ; 322( 2): 678-685.[citado 2024 nov. 05 ]
  • Source: Current Opinion in Nephrology and Hypertension. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CALLERA, Glaucia E. et al. Vascular signaling through cholesterol-rich domains: implications in hypertension. Current Opinion in Nephrology and Hypertension, v. 16, n. 2, p. 90-104, 2007Tradução . . Disponível em: https://doi.org/10.1097/mnh.0b013e328040bfbd. Acesso em: 05 nov. 2024.
    • APA

      Callera, G. E., Montezano, A. C. I., Yogi, A., Passaglia, R. de C. A. T., & Touyz, R. M. (2007). Vascular signaling through cholesterol-rich domains: implications in hypertension. Current Opinion in Nephrology and Hypertension, 16( 2), 90-104. doi:10.1097/mnh.0b013e328040bfbd
    • NLM

      Callera GE, Montezano ACI, Yogi A, Passaglia R de CAT, Touyz RM. Vascular signaling through cholesterol-rich domains: implications in hypertension [Internet]. Current Opinion in Nephrology and Hypertension. 2007 ; 16( 2): 90-104.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1097/mnh.0b013e328040bfbd
    • Vancouver

      Callera GE, Montezano ACI, Yogi A, Passaglia R de CAT, Touyz RM. Vascular signaling through cholesterol-rich domains: implications in hypertension [Internet]. Current Opinion in Nephrology and Hypertension. 2007 ; 16( 2): 90-104.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1097/mnh.0b013e328040bfbd
  • Source: Expert Review of Cardiovascular Therapy. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CALLERA, Glaucia et al. Vasoactive peptides in cardiovascular (patho)physiology. Expert Review of Cardiovascular Therapy, v. 5, n. 3, p. 531-552, 2007Tradução . . Disponível em: https://doi.org/10.1586/14779072.5.3.531. Acesso em: 05 nov. 2024.
    • APA

      Callera, G., Passaglia, R. de C. A. T., Savoia, C., Muscará, M. N., & Touyz, R. M. (2007). Vasoactive peptides in cardiovascular (patho)physiology. Expert Review of Cardiovascular Therapy, 5( 3), 531-552. doi:10.1586/14779072.5.3.531
    • NLM

      Callera G, Passaglia R de CAT, Savoia C, Muscará MN, Touyz RM. Vasoactive peptides in cardiovascular (patho)physiology [Internet]. Expert Review of Cardiovascular Therapy. 2007 ; 5( 3): 531-552.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1586/14779072.5.3.531
    • Vancouver

      Callera G, Passaglia R de CAT, Savoia C, Muscará MN, Touyz RM. Vasoactive peptides in cardiovascular (patho)physiology [Internet]. Expert Review of Cardiovascular Therapy. 2007 ; 5( 3): 531-552.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1586/14779072.5.3.531
  • Source: Clinical Science. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CALLERA, Glaucia E. et al. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clinical Science, v. 110, n. 2, p. 243-253, 2006Tradução . . Disponível em: https://doi.org/10.1042/cs20050307. Acesso em: 05 nov. 2024.
    • APA

      Callera, G. E., Passaglia, R. de C. A. T., Yogi, A., Montezano, A. C. I., & Touyz, R. M. (2006). Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clinical Science, 110( 2), 243-253. doi:10.1042/cs20050307
    • NLM

      Callera GE, Passaglia R de CAT, Yogi A, Montezano ACI, Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms [Internet]. Clinical Science. 2006 ; 110( 2): 243-253.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1042/cs20050307
    • Vancouver

      Callera GE, Passaglia R de CAT, Yogi A, Montezano ACI, Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms [Internet]. Clinical Science. 2006 ; 110( 2): 243-253.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1042/cs20050307
  • Source: Experimental Biology and Medicine. Unidade: ICB

    Assunto: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BORGHERESI, Rosa A. M. B. et al. Pharmacologic and molecular characterization of the vascular ETA receptor in the venomous snake Bothrops jararaca. Experimental Biology and Medicine, v. 231, n. 6, p. 729-735, 2006Tradução . . Acesso em: 05 nov. 2024.
    • APA

      Borgheresi, R. A. M. B., Leroy, J. M. G., Yogy, A., Dos Santos, R. A., Breno, M. C., & Passaglia, R. de C. A. T. (2006). Pharmacologic and molecular characterization of the vascular ETA receptor in the venomous snake Bothrops jararaca. Experimental Biology and Medicine, 231( 6), 729-735.
    • NLM

      Borgheresi RAMB, Leroy JMG, Yogy A, Dos Santos RA, Breno MC, Passaglia R de CAT. Pharmacologic and molecular characterization of the vascular ETA receptor in the venomous snake Bothrops jararaca. Experimental Biology and Medicine. 2006 ; 231( 6): 729-735.[citado 2024 nov. 05 ]
    • Vancouver

      Borgheresi RAMB, Leroy JMG, Yogy A, Dos Santos RA, Breno MC, Passaglia R de CAT. Pharmacologic and molecular characterization of the vascular ETA receptor in the venomous snake Bothrops jararaca. Experimental Biology and Medicine. 2006 ; 231( 6): 729-735.[citado 2024 nov. 05 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024